ASH: Daratumumab beneficial for patients with multiple myeloma
by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio
Updated on: January 26,2024
5

ASH: Daratumumab beneficial for patients with multiple myeloma
by Elana GotkineFor transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone inductio
Updated on:January 26,2024
5
